In conclusion, we performed the first pan-cancer analysis of HHLA2, which indicated a substantial difference in HHLA2 expression in most tumor tissues compared to normal tissues, and revealed an association between HHLA2 expression and clinical prognosis. The gene discussed is HHLA2; the disease is neoplasm.